- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Stilla collects $35m
Illumina helped the digital PCR technology developer secure fresh convertible bond and loan financing that will be used for international expansion and the further development of its platform.
Nov 25, 2021Deals: November 24, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Nov 24, 2021Luma Health hauls in $130m
The Texas Medical Center and Cisco-backed healthcare administration platform developer raised series C financing that took its overall funding to $160m.
Nov 24, 2021Cornerstone Robotics operates series B round
The surgical robotics developer received $78.3m in funding from investors including New World Development, Lilly Asia Ventures and Meituan's DragonBall Capital fund.
Nov 24, 2021Ieso institutes $53m series B round
Sony Innovation Fund took part in a series B round for the digital medicine technology developer as it seeks to expand in the UK and US.
Nov 24, 2021Ieso institutes $53m series B
IP Group has returned for a series B round raised by Ieso Digital Health, having initially acquired stakes in the business through its purchase of Touchstone.
Nov 24, 2021Neurophth sees its way to over $60m
Sunshine Insurance took part in the eye-focused gene therapy developer's series C round, which pushed its overall funding past $140m.
Nov 24, 2021Daily Deal Round Up: November 23, 2021
Coinbase Ventures contributed to a $55m round for music-focused NFT platform developer Royal while neural search technology developer Jina AI raised $30m in an SAP-backed round.
Nov 23, 2021Treadwell Therapeutics steps to series B round
Sino Biopharmaceutical co-led the oncology treatment developer's latest round, in which it raised over $91m in funding.
Nov 23, 2021Vigil Neuroscience files for IPO
The neurodegenerative disease therapy developer has set a $100m placeholder target for an offering following $140m in funding from investors including Amgen and Pivotal BioVentures.
Nov 23, 2021Chroma colours in $125m series A
Bringing together researchers from Italy and the US, Chroma Medicine has emerged out of stealth with series A financing led by Cormorant Asset Management.
Nov 23, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
